ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

9791	Companies
196216	Keywords
127215	Articles
104319	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 01/23/2025 at 22:05, 1 year ago

Abivax annonce la présentation de sept abstracts sur l'utilisation d’Obefazimod dans le traitement de la rectocolite hémorragique lors de l’édition 2025 du 20e congrès annuel de la ECCO
Abivax annonce la présentation de sept abstracts sur l'utilisation d’Obefazimod dans le traitement de la rectocolite hémorragique lors de l’édition 2025 du 20e congrès annuel de la European Crohn’s and Colitis Organization

Abivax Obefazimod Rectocolite Hémorragique ECCO Congrès
PRESS RELEASE

published on 01/23/2025 at 22:05, 1 year ago

Abivax annonce la présentation de sept abstracts sur l'utilisation d’Obefazimod dans le traitement de la rectocolite hémorragique lors de l’édition 2025 du 20e congrès annuel de la ECCO
Abivax annonce la présentation de sept abstracts sur l'utilisation d’Obefazimod dans le traitement de la rectocolite hémorragique lors de l’édition 2025 du 20e congrès annuel de la ECCO

Abivax Obefazimod Rectocolite Hémorragique ECCO Congrès
PRESS RELEASE

published on 01/23/2025 at 22:05, 1 year ago

Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress
Abivax announces presentation of seven abstracts for Obefazimod in ulcerative colitis at 2025 European Crohn's and Colitis Organization 20th Annual Congress

Abivax Obefazimod Ulcerative Colitis Clinical Trials ECCO
PRESS RELEASE

published on 01/09/2025 at 17:44, 1 year ago

Abivax franchit une étape clé dans le recrutement de l’essai de phase 3 ABTECT
Abivax franchit une étape clé dans le recrutement de l'essai de phase 3 ABTECT pour le traitement de la RCH. Objectif de recrutement proche de 82%. Premiers résultats attendus en 2025

Abivax Recrutement Phase 3 ABTECT RCH
BRIEF

published on 01/09/2025 at 17:40, 1 year ago

Abivax franchit une étape clé dans le recrutement de l'essai de phase 3 ABTECT

Abivax Obefazimod Rectocolite Hémorragique Essai De Phase 3 Résultats Cliniques
BRIEF

published on 01/09/2025 at 17:40, 1 year ago

Abivax Reaches Key Enrollment Milestone in Phase 3 ABTECT Trial

Abivax Obefazimod Ulcerative Colitis Phase 3 Trial Clinical Results
PRESS RELEASE

published on 01/09/2025 at 17:35, 1 year ago

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment
Abivax achieves key milestone in Phase 3 ABTECT trial enrollment with 82% of target participants enrolled for evaluating obefazimod in ulcerative colitis, aiming for NDA submission by H2 2026

Abivax Obefazimod Ulcerative Colitis Phase 3 ABTECT Trial
BRIEF

published on 12/23/2024 at 22:10, 1 year 1 month ago

Abivax Announces Board Resignation

Abivax Obefazimod Board Resignation Truffle Capital Philippe Pouletty
BRIEF

published on 12/23/2024 at 22:10, 1 year 1 month ago

Abivax annonce la démission de son conseil d'administration

Abivax Obefazimod Démission Du Conseil D'administration La Capitale De La Truffe Philippe Pouletty
PRESS RELEASE

published on 12/23/2024 at 22:05, 1 year 1 month ago

Abivax annonce une modification de la composition de son Conseil d'administration
Abivax annonce la démission du Dr Philippe Pouletty en tant qu'administrateur et recherche un nouveau membre du Conseil d'administration. Plus d'informations sur www.abivax.com

Abivax Conseil D'administration Rectocolite Hémorragique Démission Maladies Inflammatoires

Accesswire

Published on 02/03/2026 at 14:29, 11 minutes ago

Worksport Ltd. Announces Strategic Partnership With Potomac International Partners to Accelerate Federal Government and Commercial Market Adoption of Clean Energy Ecosystem
Published on 02/03/2026 at 13:58, 42 minutes ago

QNX and Haleytek Join Forces to Deliver Software-Defined Audio for Volvo Cars' EX60 EV SUV
Published on 02/03/2026 at 13:30, 1 hour 10 minutes ago

Alset AI's Lyken.AI Secures Cloud Compute Services Purchase Order from Leading Multinational Technology and Telecommunications Company
Published on 02/03/2026 at 13:30, 1 hour 10 minutes ago

Lahontan Selects RESPEC and Kappes Cassiday to Update Santa Fe Mineral Resource Estimate and PEA
Published on 02/03/2026 at 13:30, 1 hour 10 minutes ago

ESGold's Integrated 3D Geological Model Identifies Deep, Expanding Mineralized Corridor at Montauban, Supporting District-Scale Exploration Potential

View all ACCESSWIRE

EQS Group

Published on 02/03/2026 at 14:20, 20 minutes ago

TCL Professional presents Olympic-level digital signage and commercial LED solutions at ISE 2026
Published on 02/03/2026 at 12:55, 1 hour 45 minutes ago

ISX Financial EU PLC Appoints Andreas Artemiou as Chief Risk Officer
Published on 02/03/2026 at 12:45, 1 hour 55 minutes ago

OneDosh Raises $3M Pre-Seed to Build Stablecoin-Powered Infrastructure for Cross-Border Payments
Published on 02/03/2026 at 12:15, 2 hours 25 minutes ago

Global Leading RWA Network Plume Lowers the Barrier for Korean Institutional Investment Through the KRW1 Stablecoin
Published on 02/03/2026 at 12:08, 2 hours 31 minutes ago

Original-Research: Almonty Industries Inc. (von Sphene Capital GmbH): Buy

Les Echos

Published on 02/03/2026 at 08:30, 6 hours 10 minutes ago

cegedim.cloud lance la nouvelle version d’Enercare, son module de calcul et de pilotage de l’empreinte carbone
Published on 02/03/2026 at 08:00, 6 hours 40 minutes ago

EURAZEO & PANTHEON ESTABLISH A NEARLY €500 MILLION PRIVATE DEBT CONTINUATION VEHICLE
Published on 02/03/2026 at 08:00, 6 hours 40 minutes ago

EURAZEO ET PANTHEON METTENT EN PLACE UN VÉHICULE DE CONTINUATION DE DETTE PRIVÉE DE PRÈS DE €500 MILLIONS
Published on 02/03/2026 at 08:00, 6 hours 40 minutes ago

Neoen lance la construction de trois nouveaux parcs solaires en France pour une capacité totale de 230 MWc
Published on 02/03/2026 at 08:00, 6 hours 40 minutes ago

Neoen launches three new solar farms in France with a total capacity of 230 MWp

View all LES ECHOS COMFI WIRE